RAPID DEVELOPMENT OF RENAL FAILURE SECONDARY TO AA-TYPE AMYLOIDOSIS IN A PATIENT WITH POLYMYALGIA RHEUMATICA

被引：5

作者：

Javaid, Muhammad Masoom ^{[1
]}

Kamalanathan, Manivarma ^{[1
]}

Sui Phin Kon ^{[1
]}

机构：

[1] Kings Coll Hosp NHS Fdn Trust, Dept Nephrol, London SE5 9RS, England

来源：

JOURNAL OF RENAL CARE | 2010年 / 36卷 / 04期

关键词：

AA amyloidosis; Polymyalgia rheumatica; Renal failure;

D O I：

10.1111/j.1755-6686.2010.00200.x

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

Polymyalgia rheumatica (PMR) is a common chronic inflammatory disorder affecting patients over the age of 50. Renal involvement in PMR is extremely rare and very few cases of AA amyloidosis secondary to PMR have been described in literature. We present a case of a patient with history PMR who developed nephrotic range proteinuria and rapidly deteriorating renal function secondary to AA amyloidosis within 18 months of the onset of symptoms of PMR. This case reinforces the association of PMR with secondary AA amyloidosis and highlights the importance of monitoring renal function in patients with PMR.

引用

页码：199 / 202

页数：4

共 11 条

[1]

Altiparmak MR, 2001, SCAND J RHEUMATOL, V30, P114

[2] Eprodisate for the treatment of renal disease in AA amyloidosis [J].

Dember, Laura M. ;

Hawkins, Philip N. ;

Hazenberg, Bouke P. C. ;

Gorevic, Peter D. ;

Merlini, Giampaolo ;

Butrimiene, Irena ;

Livneh, Avi ;

Lesnyak, Olga ;

Puechal, Xavier ;

Lachmann, Helen J. ;

Obici, Laura ;

Balshaw, Robert ;

Garceau, Denis ;

Hauck, Wendy ;

Skinner, Martha .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (23) :2349-2360

[3] Amyloidosis-associated kidney disease [J].

Dember, Laura M. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (12) :3458-3471

[4] Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica [J].

Escribá, A ;

Morales, E ;

Albizúa, E ;

Herrero, JC ;

Ortuño, T ;

Carreño, A ;

Dominguez-Gil, B ;

Praga, M .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) :137-140

[5] Anti-tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides -: A followup report of tolerability and efficacy [J].

Gottenberg, JE ;

Merle-Vincent, F ;

Bentaberry, F ;

Allanore, Y ;

Berenbaum, F ;

Fautrel, B ;

Combe, B ;

Durbach, A ;

Sibilia, J ;

Dougados, M ;

Mariette, X .

ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :2019-2024

[6] Presentation, survival and prognostic markers in AA amyloidosis [J].

Joss, N ;

McLaughlin, K ;

Simpson, K ;

Boulton-Jones, JM .

QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2000, 93 (08) :535-542

[7] Natural history and outcome in systemic AA amyloidosis [J].

Lachmann, Helen J. ;

Goodman, Hugh J. B. ;

Gilbertson, Janet A. ;

Gallimore, J. Ruth ;

Sabin, Caroline A. ;

Gillmore, Julian D. ;

Hawkins, Philip N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (23) :2361-2371

[8]

Monteagudo M, 1997, J RHEUMATOL, V24, P605

[9]

Moraga I, 2001, CLIN NEPHROL, V56, P402

[10] Polymyalgia rheumatica and giant-cell arteritis [J].

Salvarani, Carlo ;

Cantini, Fabrizio ;

Hunder, Gene G. .

LANCET, 2008, 372 (9634) :234-245

← 1 2 →